Adjuvant Dexmedetomidine and Tramadol in Subcostal Transversus Abdominis Plan Block
Status:
Completed
Trial end date:
2023-04-03
Target enrollment:
Participant gender:
Summary
In this study, dexmedetomidine and tramadol were added as adjuvant to bupivacaine in
transversus abdominis plane block (TAP), intraoperative hemodynamics, opioid consumption,
muscle relaxant use, postoperative analgesic effects and side effects (such as
nausea-vomiting) were evaluated.